
ArriVent BioPharma, Inc.
USD34.87
+0.50 (+1.46%)
CEO
Zhengbin Yao
IPO Date
2024-01-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$33.58
Prev. Close
$34.37
Day Low
$33.58
Day High
$35.19
52W Low
$16.10
52W High
$35.83
Market Cap
$1.62B
Volume
0.01M
| 23 Mar 2026 |
| B. Riley Securities |
| Buy |
| Buy |
| maintain |
| 6 Mar 2026 | Oppenheimer | Outperform | Outperform | maintain |
| 6 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 6 Mar 2026 | Citigroup | Buy | Buy | maintain |
| 11 Nov 2025 | Citigroup | Buy | Buy | maintain |
| 12 Aug 2025 | HC Wainwright & Co. | Buy | Buy | maintain |
| 12 Aug 2025 | Citigroup | Buy | Buy | maintain |